Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 25/02/20 → 24/02/25 |
Keywords
- clinical trial
- phase 3 study
- treatment efficacy
- Lymphoma
Clinical Trial Phase
- Phase III (a & b)
A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
- Opat, Stephen (Primary Chief Investigator (PCI))
Project: Research